Sanesco International
Private Company
Funding information not available
Overview
Sanesco International is a private, commercial-stage company that has developed a service and product platform centered on neuroendocrine diagnostics and personalized wellness. Its core offering is the NeuroWellness Program, which provides healthcare providers with tools like neurotransmitter and hormone testing to identify imbalances and recommend targeted nutritional formulas. With nearly two decades of operation, Sanesco targets the growing market for integrative and personalized medicine, serving practitioners rather than direct-to-consumer. The company's business model blends diagnostic services with supplement-based product sales.
Technology Platform
Integrated diagnostic and therapeutic platform focusing on HPA axis assessment. Includes urine-based neurotransmitter testing, saliva-based hormone testing, and algorithmic recommendation of proprietary nutraceutical formulas (NeuroWellness Formulas) based on test results.
Opportunities
Risk Factors
Competitive Landscape
Sanesco competes with other functional medicine diagnostic labs (e.g., Genova Diagnostics, Doctor's Data) and numerous nutraceutical companies. Its differentiation lies in its specific focus on the HPA axis and its closed-loop system of testing paired with targeted formula recommendations.